Newswise — Fairfax, Va., July 1, 2014—The American Society for Radiation Oncology (ASTRO) has selected 30 distinguished members of the Society to receive the Fellow of ASTRO designation (FASTRO). The 2014 Class of Fellows will receive the recognition during the Awards Ceremony on Tuesday, September 16, at ASTRO’s 56th Annual Meeting, September 14-17, 2014, at Moscone Center in San Francisco.

Awarded annually since 2006, the Fellows Program honors radiation oncology leaders who have been an ASTRO member for at least 15 years, who have contributed the equivalent of 10 years of service to ASTRO and who have made substantial contributions to the field of radiation oncology in the areas of research, education, patient care or service, and leadership. Including the 2014 Class of 30 Fellows, 242 of ASTRO’s more than 10,000 members worldwide have received the FASTRO designation.

Candidates are nominated by a current ASTRO Fellow and supported by three additional ASTRO members. A 10-member Fellows Selection Committee reviewed all of the nominations and presented a slate of recommended Fellows to ASTRO’s Board of Directors for final approval.

“These 30 new Fellows have contributed significantly to ASTRO, the specialty and cancer patients worldwide. Their leadership in and service to research, education and patient care efforts will continue to impact the cancer care we provide our patients,” said ASTRO President Bruce G. Haffty, MD, FASTRO. “Congratulations to my esteemed colleagues on receiving the ASTRO Fellow designation.”

The members of the 2014 Fellows class are:

• John M. Buatti, MD, chair of and professor in the Department of Radiation Oncology, University of Iowa, Iowa City, Iowa• Thomas F. Delaney, MD, medical director of the Francis H. Burr Proton Therapy Center, co-director of the Center for Sarcoma and Connective Tissue Oncology and a radiation oncologist, Massachusetts General Hospital, Boston• Adam Dicker, MD, PhD, chair of and professor in the Department of Radiation Oncology, Thomas Jefferson University, Philadelphia• Avraham Eisbruch, MD, the Newman Family Professor of Radiation Oncology, University of Michigan, Ann Arbor, Michigan• Eduardo Fernandez, MD, PhD, senior vice-president of medical affairs and medical director for Latin America, 21st Century Oncology, Plantation, Florida• David Gaffney, MD, PhD, medical director of the Radiation Oncology Clinic and vice-chair of and professor in the Department of Radiation Oncology, Huntsman Cancer Institute and University of Utah, Salt Lake City• Adam Garden, MD, associate medical director of the Head and Neck Center and professor of radiation oncology, MD Anderson Cancer Center, Houston• Katherine L. Griem, MD, professor of radiation oncology, Rush University Medical Center, Chicago• William F. Hartsell, MD, medical director, CDH Proton Center, Warrenville, Illinois• James Alan Hayman, MD, MBA, associate chair for clinical activities and professor of radiation oncology, University of Michigan, Ann Arbor, Michigan• I-Chow Hsu, MD, vice-chair of and professor in the Department of Radiation Oncology, University of California, San Francisco• Lisa Kachnic, MD, chair of the Department of Radiation Oncology, Boston Medical Center, Boston• Brian Kavanagh, MD, MPH, vice-chair and clinical practice director of and professor in the Department of Radiation Oncology, University of Colorado, Aurora, Colorado• Timothy Kinsella, MD, MS, MA, research scholar professor in the Department of Radiation Oncology, Warren Alpert Medical School, Providence, Rhode Island• Andre Konski, MD, MBA, MA, clinical professor in the Department of Radiation Oncology, University of Pennsylvania, West Chester, Pennsylvania • Patrick Kupelian, MD, vice-chair of clinical operations and clinical research and professor of radiation oncology, University of California, Los Angeles• Quynh-Thu Le, MD, chair of the Department of Radiation Oncology and the Katherine Dexter McCormick and Stanley McCormick Memorial Professor, Stanford University, Stanford, California• W. Robert Lee, MD, MS, MEd, professor of radiation oncology, Duke University School of Medicine, Durham, North Carolina• Stephen Lutz, MD, attending radiation oncologist, Blanchard Valley Regional Cancer Center, Findlay, Ohio• C.M. Charlie Ma, PhD, vice-chair of the Department of Radiation Oncology and director and professor of medical physics, Fox Chase Cancer Center, Philadelphia• Bruce D. Minsky, MD, deputy division head, director of clinical research, Frank T. McGraw Memorial Chair in the Study of Cancer and professor in the Division of Radiation Oncology, MD Anderson Cancer Center, Houston• Najeeb Mohideen, MD, attending radiation oncologist, Northwest Community Hospital, Arlington Heights, Illinois• Simon N. Powell, MD, PhD, chair of the Department of Radiation Oncology and the Enid A. Haupt Chair in Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York• Mack Roach III, MD, chair of and professor in the Department of Radiation Oncology, University of California, San Francisco• Kenneth E. Rosenzweig, MD, chair of and professor in the Department of Radiation Oncology, Icahn School of Medicine at Mount Sinai, New York• Christopher J. Schultz, MD, professor of radiation oncology, Medical College of Wisconsin, Milwaukee• Dennis Shrieve, MD, PhD, chair of and professor in the Department of Radiation Oncology and the Rudolph P. and Edna S. Reese Research Professor in Radiation Oncology, University of Utah, Salt Lake City• Paul W. Sperduto, MD, MPP, co-director of the Gamma Knife Center, University of Minnesota, Minneapolis, and radiation oncologist, Minneapolis Radiation Oncology, Waconia, Minnesota• Maria Werner-Wasik, MD, director of clinical research and professor in the Department of Radiation Oncology, Thomas Jefferson University, Philadelphia• Jeffrey Williamson, PhD, professor of medical physics, Virginia Commonwealth University Medical Center, Richmond, Virginia For more information about ASTRO’s 56th Annual Meeting, visit www.astro.org/annualmeeting.

For press registration and media policies for ASTRO’s 56th Annual Meeting, visit www.astro.org/AMpress.

ABOUT ASTROASTRO is the premier radiation oncology society in the world, with more than 10,000 members who are physicians, nurses, biologist, physicists, radiation therapists, dosimetrists and other health care professionals that specialize in treating patients with radiation therapies. As the leading organization in radiation oncology, the Society is dedicated to improving patient care through professional education and training, support for clinical practice and health policy standards, advancement of science and research, and advocacy. ASTRO publishes two medical journals, International Journal of Radiation Oncology • Biology • Physics (www.redjournal.org) and Practical Radiation Oncology (www.practicalradonc.org); developed and maintains an extensive patient website, www.rtanswers.org; and created the Radiation Oncology Institute (www.roinstitute.org), a non-profit foundation to support research and education efforts around the world that enhance and confirm the critical role of radiation therapy in improving cancer treatment. To learn more about ASTRO, visit www.astro.org.###